Xu-Dong Wang

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 12

Top Venues

Science advances

International journal of molecular sciences

EMBO reports

eLife

University of Texas Southwestern Medical Center

Sun Yat-Sen University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Southwestern Medical Center Feb 16 2016

United States

PostDoc :: Biochemistry

Education History

Sun Yat-Sen University - Sep 30 2015

China

PHD

Huazhong Normal University Sep 01 2004 - Jul 01 2008

China

BSC :: School of Chemistry

Publications

Chiho Kim, Xu-Dong Wang, Zhengshuai Liu, Jianwei Hao, Shuai Wang, Peng Li, Zhenzhen Zi, Qing Ding, Seoyeon Jang, Jiwoong Kim, Yikai Luo, Kenneth E Huffman, Shreoshi Pal Choudhuri, Sofia Del Rio, Ling Cai, Han Liang, Benjamin J Drapkin, John D Minna, Yonghao Yu
Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science advances 10 (3) (2024)
Chiho Kim, Xu-Dong Wang, Zhengshuai Liu, Jianwei Hao, Shuai Wang, Peng Li, Zhenzhen Zi, Qing Ding, Seoyeon Jang, Jiwoong Kim, Yikai Luo, Kenneth E Huffman, Shreoshi Pal Choudhuri, Sofia Del Rio, Ling Cai, Han Liang, Benjamin J Drapkin, John D Minna, Yonghao Yu
Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science advances 10 (3) (2024)
Chiho Kim, Xu-Dong Wang, Zhengshuai Liu, Jianwei Hao, Shuai Wang, Peng Li, Zhenzhen Zi, Qing Ding, Seoyeon Jang, Jiwoong Kim, Yikai Luo, Kenneth E Huffman, Shreoshi Pal Choudhuri, Sofia Del Rio, Ling Cai, Han Liang, Benjamin J Drapkin, John D Minna, Yonghao Yu
Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science advances 10 (3) (2024)
Chiho Kim, Xu-Dong Wang, Zhengshuai Liu, Jianwei Hao, Shuai Wang, Peng Li, Zhenzhen Zi, Qing Ding, Seoyeon Jang, Jiwoong Kim, Yikai Luo, Kenneth E Huffman, Shreoshi Pal Choudhuri, Sofia Del Rio, Ling Cai, Han Liang, Benjamin J Drapkin, John D Minna, Yonghao Yu
Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science advances 10 (3) (2024)
Havish S Kantheti, Michael A Hale, Shreoshi Pal Choudhuri, Huocong Huang, Xu-Dong Wang, Yalda Zolghadri, Giulio Innamorati, Sai Prasada Rao Manikonda, Naviya Reddy, Sarthak Reddy, Rahul K Kollipara, Valbona Lumani, Luc Girard, Yakov Bezrukov, Pavel S Demenkov, Raymond J MacDonald, Rolf A Brekken, Yonghao Yu, Thomas M Wilkie
Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma. International journal of molecular sciences 25 (12) (2024)
Chiho Kim, Xu-Dong Wang, Zhengshuai Liu, Jianwei Hao, Shuai Wang, Peng Li, Zhenzhen Zi, Qing Ding, Seoyeon Jang, Jiwoong Kim, Yikai Luo, Kenneth E Huffman, Shreoshi Pal Choudhuri, Sofia Del Rio, Ling Cai, Han Liang, Benjamin J Drapkin, John D Minna, Yonghao Yu
Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science advances 10 (3) (2024)
Havish S Kantheti, Michael A Hale, Shreoshi Pal Choudhuri, Huocong Huang, Xu-Dong Wang, Yalda Zolghadri, Giulio Innamorati, Sai Prasada Rao Manikonda, Naviya Reddy, Sarthak Reddy, Rahul K Kollipara, Valbona Lumani, Luc Girard, Yakov Bezrukov, Pavel S Demenkov, Raymond J MacDonald, Rolf A Brekken, Yonghao Yu, Thomas M Wilkie
Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma. International journal of molecular sciences 25 (12) (2024)
Peng Li, Yuanli Zhen, Chiho Kim, Zhengshuai Liu, Jianwei Hao, Heping Deng, Hejun Deng, Min Zhou, Xu-Dong Wang, Tian Qin, Yonghao Yu
Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA -mutated cancer. Science advances 9 (43) (2023)
Xu-Dong Wang, Chen-Si Zhao, Qi-Long Wang, Qi Zeng, Xing-Zhi Feng, Lianbo Li, Zhi-Long Chen, Yu Gong, Jiahuai Han, Yingqiu Li
The p38-interacting protein p38IP suppresses TCR and LPS signaling by targeting TAK1. EMBO reports 21 (7) (2020)
Chiho Kim, Xu-Dong Wang, Yonghao Yu
PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response. eLife 9 (2020)
Xu-Dong Wang, Rongkuan Hu, Qing Ding, Trisha K Savage, Kenneth E Huffman, Noelle Williams, Melanie H Cobb, John D Minna, Jane E Johnson, Yonghao Yu
Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells. Nature communications 10 (1) (2019)
Xiao Yu, Qi-Long Wang, Yue-Fang Li, Xu-Dong Wang, Anlong Xu, Yingqiu Li
A novel miR-200b-3p/p38IP pair regulates monocyte/macrophage differentiation. Cell discovery 2 (2016)

Xu-Dong Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xu-Dong Wang